Earnings Call · Q1 FY2025·2025-05-06

Q1 25EPS +4.76%·Rev n/aQ4 24EPS +65.95%·Rev n/aQ3 24EPS +21.43%·Rev n/aQ2 24EPS +20.75%·Rev n/a⚠ consensus missing

Arcutis Biotherapeutics, Inc. ARQT

Amanda Sheldon — Investor Relations

Frank Watanabe — President and Chief Executive Officer

Todd Edwards — Chief Commercial Officer

Patrick Burnett — Chief Medical Officer

Latha Vairavan — Chief Financial Officer

−4.3%1d on move date−4.8% vs SPY3d−5.5%5d−3.5%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ARQT calls or request research access.

More ARQT calls Browse calls Request research access